Skip to content

Clinical trials

Endometrial Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Country / region: Canada Clear all

123 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20022
20031
20042
20051
20061
20072
20085
20092
20103
20111
20126
20131
20143
20153
20165
20172
20184
20197
20209
202111
20229
202311
20244
202512
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Recruiting31
Active, not recruiting20
Terminated12
Unknown status4
Not yet recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca9
Gynecologic Oncology Group8
University Health Network, Toronto8
Merck Sharp & Dohme LLC7
National Cancer Institute (NCI)7
GlaxoSmithKline5
McGill University4
University of British Columbia4
NCIC Clinical Trials Group3
Novartis Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms123
Ovarian Neoplasms33
Uterine Cervical Neoplasms25
Breast Neoplasms18
Colorectal Neoplasms15
Stomach Neoplasms15
Neoplasms14
Carcinoma, Non-Small-Cell Lung13
Esophageal Neoplasms10
Neoplasm Metastasis10

Trials

Showing 1 to 25 of 123. Each trial links to its page on Pharma Observatory.

23 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.